p‐cymene impairs SARS‐CoV‐2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS‐CoV‐2 nucleocapsid protein and H1N1 nucleoprotein

Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been advanced, while natural products have also been tested. Here, we propose that p‐cymene, a natural monoterpene, can act as a potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagiotopoulos, Athanasios, Tseliou, Melpomeni, Karakasiliotis, Ioannis, Kotzampasi, Danai‐Maria, Daskalakis, Vangelis, Kesesidis, Nikolaos, Notas, George, Lionis, Christos, Kampa, Marilena, Pirintsos, Stergios, Sourvinos, George, Castanas, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204097/
https://www.ncbi.nlm.nih.gov/pubmed/34128351
http://dx.doi.org/10.1002/prp2.798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204097/
https://www.ncbi.nlm.nih.gov/pubmed/34128351
http://dx.doi.org/10.1002/prp2.798

Ejemplares similares